Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation
about
The Monoamine Brainstem Reticular Formation as a Paradigm for Re-Defining Various Phenotypes of Parkinson's Disease Owing Genetic and Anatomical Specificity.Structure, Distribution, and Genetic Profile of α-Synuclein and Their Potential Clinical Application in Parkinson's Disease.α-Synuclein and Parkinsonism: Updates and Future Perspectives.Multiple system atrophy: pathogenic mechanisms and biomarkers.Nanomolar oligomerization and selective co-aggregation of α-synuclein pathogenic mutants revealed by single-molecule fluorescence.Multisystem Lewy body disease and the other parkinsonian disorders.Progression of alpha-synuclein pathology in multiple system atrophy of the cerebellar type.Multiple system atrophy: genetic risks and alpha-synuclein mutations.Neuropathology of genetic synucleinopathies with parkinsonism: Review of the literature.Mitochondrial function and autophagy: integrating proteotoxic, redox, and metabolic stress in Parkinson's disease.Unveiling a Selective Mechanism for the Inhibition of α-Synuclein Aggregation by β-Synuclein.Multiple variants in families with amyotrophic lateral sclerosis and frontotemporal dementia related to C9orf72 repeat expansion: further observations on their oligogenic nature.Multiple System Atrophy: An Oligodendroglioneural Synucleinopathy.Advancing Stem Cell Models of Alpha-Synuclein Gene Regulation in Neurodegenerative Disease.Modeling Parkinson's Disease Using Patient-specific Induced Pluripotent Stem Cells
P2860
Q30357944-9B79A528-ACE7-45B2-B90F-3EB6107E3104Q33701172-DA52E38B-C657-47AC-9BBF-C030AAB7825BQ38742153-1AC12C66-30ED-4558-A049-9BE24F23828FQ38813304-F3783874-1979-488E-B499-2F09C81D10C5Q39149504-D3C693C3-CEA9-40F7-9EA5-C4231E9CAB75Q40260539-503F9C07-9455-4E7A-94C6-CF815376EB44Q42500238-5E8EE19E-EAC4-4E33-9C43-E36745AE9D3AQ47309944-08117EA9-E2A7-4378-986C-BFE668B30B82Q47619453-38524024-3E5A-45BE-8AD5-C0C28CCDD93AQ47653685-B0A7F5C4-5D3F-4B95-A552-CF3274113BC2Q48175893-CEEFA0CA-2845-4169-90AA-A76FBF4FE4CBQ48269119-AF386F2F-BB04-4A15-9F6C-B0CD6D1990BDQ49562668-03697BC3-8A47-4293-824C-7FD710783634Q52568381-E64DC249-3B8B-4DCA-9C58-0765C1413DF5Q58726898-8B831743-AC08-49C7-8983-07BD95DD16D5
P2860
Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Distinct clinical and neuropat ...... duplication and H50Q mutation
@ast
Distinct clinical and neuropat ...... duplication and H50Q mutation
@en
type
label
Distinct clinical and neuropat ...... duplication and H50Q mutation
@ast
Distinct clinical and neuropat ...... duplication and H50Q mutation
@en
prefLabel
Distinct clinical and neuropat ...... duplication and H50Q mutation
@ast
Distinct clinical and neuropat ...... duplication and H50Q mutation
@en
P2093
P2860
P50
P1476
Distinct clinical and neuropat ...... duplication and H50Q mutation
@en
P2093
Aoife P Kiely
Christos Proukakis
Eleanna Kara
Helen C Roberts
Helen Ling
Henry Houlden
Huw R Morris
Janice L Holton
Patrick A Lewis
P2860
P2888
P356
10.1186/S13024-015-0038-3
P577
2015-08-27T00:00:00Z
P5875
P6179
1019940469